Department of Pharmacology and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, IL, USA.
Department of Pharmacology and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, IL, USA; Department of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, Chicago, IL 60628, USA.
Cell Rep. 2019 Apr 16;27(3):793-805.e4. doi: 10.1016/j.celrep.2019.03.053.
Alveolar macrophages (AMs), upon sensing pathogens, trigger host defense by activating toll-like receptor 4 (TLR4), but the counterbalancing mechanisms that deactivate AM inflammatory signaling and prevent lethal edema, the hallmark of acute lung injury (ALI), remain unknown. Here, we demonstrate the essential role of AM protease-activating receptor 2 (PAR2) in rapidly suppressing inflammation to prevent long-lasting injury. We show that thrombin, released during TLR4-induced lung injury, directly activates PAR2 to generate cAMP, which abolishes Ca entry through the TRPV4 channel. Deletion of PAR2 and thus the accompanying cAMP generation augments Ca entry via TRPV4, causing sustained activation of the transcription factor NFAT to produce long-lasting TLR4-mediated inflammatory lung injury. Rescuing thrombin-sensitive PAR2 expression or blocking TRPV4 activity in PAR2-null AMs restores their capacity to resolve inflammation and reverse lung injury. Thus, activation of the thrombin-induced PAR2-cAMP cascade in AMs suppresses TLR4 inflammatory signaling to reinstate tissue integrity.
肺泡巨噬细胞(AMs)在感知病原体后,通过激活 Toll 样受体 4(TLR4)触发宿主防御,但尚不清楚哪些机制能够使 AM 炎症信号失活并防止致命性水肿,而水肿正是急性肺损伤(ALI)的标志。在这里,我们证明了 AM 蛋白酶激活受体 2(PAR2)在迅速抑制炎症以防止持久损伤方面的重要作用。我们发现,TLR4 诱导的肺损伤过程中释放的凝血酶可直接激活 PAR2 以产生 cAMP,从而消除 TRPV4 通道的 Ca2+内流。PAR2 缺失和随之而来的 cAMP 生成增加通过 TRPV4 导致 Ca2+内流增加,从而使转录因子 NFAT 持续激活,导致长期的 TLR4 介导的炎症性肺损伤。恢复 PAR2 敏感的 PAR2 表达或在 PAR2 缺失的 AMs 中阻断 TRPV4 活性,可恢复其缓解炎症和逆转肺损伤的能力。因此,凝血酶诱导的 PAR2-cAMP 级联在 AMs 中的激活可抑制 TLR4 炎症信号,恢复组织完整性。